Shattuck Labs, Inc. (STTK)
NASDAQ: STTK · Real-Time Price · USD
7.53
-0.19 (-2.46%)
At close: Apr 28, 2026, 4:00 PM EDT
7.48
-0.05 (-0.61%)
After-hours: Apr 28, 2026, 5:51 PM EDT
Shattuck Labs Employees
Shattuck Labs had 40 employees as of December 31, 2025. The number of employees decreased by 4 or -9.09% compared to the previous year.
Employees
40
Change (1Y)
-4
Growth (1Y)
-9.09%
Revenue / Employee
$25,000
Profits / Employee
-$1,220,225
Market Cap
569.13M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| ProKidney | 231 |
| CorMedix | 191 |
| Rigel Pharmaceuticals | 174 |
| Kyverna Therapeutics | 130 |
| Ocugen | 116 |
| Adlai Nortye | 109 |
| Aclaris Therapeutics | 73 |
| Prothena Corporation | 67 |
STTK News
- 7 weeks ago - Shattuck Labs Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 2 months ago - Shattuck Labs Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Shattuck Labs Announces Participation in Upcoming March Investor Conferences - GlobeNewsWire
- 2 months ago - Shattuck Labs Announces Participation in Upcoming Piper Sandler Virtual Novel Targets in Immunology Symposium - GlobeNewsWire
- 4 months ago - Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 months ago - Shattuck Labs Transcript: Evercore ISI 8th Annual HealthCONx Conference - Transcripts
- 5 months ago - Shattuck Labs Transcript: Piper Sandler 37th Annual Healthcare Conference - Transcripts
- 5 months ago - Analyst Upgrade Boosts Shattuck On Confidence In Next-Gen Inflammatory Bowel Disease Therapy - Benzinga